These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2776818)
21. Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study. Senin U; Abate G; Fieschi C; Gori G; Guala A; Marini G; Villardita C; Parnetti L Eur Neuropsychopharmacol; 1991 Dec; 1(4):511-7. PubMed ID: 1822317 [TBL] [Abstract][Full Text] [Related]
22. Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries. Nakamura K CNS Drug Rev; 2002; 8(1):70-89. PubMed ID: 12070527 [TBL] [Abstract][Full Text] [Related]
24. Erk1/2 and Akt kinases are involved in the protective effect of aniracetam in astrocytes subjected to simulated ischemia in vitro. Gabryel B; Pudelko A; Malecki A Eur J Pharmacol; 2004 Jun; 494(2-3):111-20. PubMed ID: 15212964 [TBL] [Abstract][Full Text] [Related]
25. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions. Zajaczkowski W; Danysz W Pharmacol Biochem Behav; 1997 Jan; 56(1):21-9. PubMed ID: 8981605 [TBL] [Abstract][Full Text] [Related]
26. Effects of aniracetam on one-trial passive avoidance tests and cholinergic neurons in discrete brain regions of rats. Toide K Arch Int Pharmacodyn Ther; 1989; 298():25-37. PubMed ID: 2757465 [TBL] [Abstract][Full Text] [Related]
27. Effects of aniracetam on bladder overactivity in rats with cerebral infarction. Nakada Y; Yokoyama O; Komatsu K; Kodama K; Yotsuyanagi S; Niikura S; Nagasaka Y; Namiki M J Pharmacol Exp Ther; 2000 Jun; 293(3):921-8. PubMed ID: 10869393 [TBL] [Abstract][Full Text] [Related]
28. Effects of aniracetam on extracellular levels of transmitter amino acids in the hippocampus of the conscious gerbils: an intracranial microdialysis study. Yu S; Cai J Neurosci Lett; 2003 Mar; 339(3):187-90. PubMed ID: 12633884 [TBL] [Abstract][Full Text] [Related]
29. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver. Saletu B; Grünberger J; Linzmayer L Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816 [TBL] [Abstract][Full Text] [Related]
30. Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests. Somnier FE; Ostergaard MS; Boysen G; Bruhn P; Mikkelsen BO Psychopharmacology (Berl); 1990; 101(1):43-6. PubMed ID: 2188276 [TBL] [Abstract][Full Text] [Related]
31. Quantitative EEG changes due to cerebral vasoconstriction. Indomethacin versus hyperventilation-induced reduction in cerebral blood flow in normal subjects. Kraaier V; Van Huffelen AC; Wieneke GH; Van der Worp HB; Bär PR Electroencephalogr Clin Neurophysiol; 1992 Mar; 82(3):208-12. PubMed ID: 1371441 [TBL] [Abstract][Full Text] [Related]
32. A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats. Takeo S; Niimura M; Miyake-Takagi K; Nagakura A; Fukatsu T; Ando T; Takagi N; Tanonaka K; Hara J Br J Pharmacol; 2003 Feb; 138(4):642-54. PubMed ID: 12598418 [TBL] [Abstract][Full Text] [Related]
33. N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. Pizzi M; Consolandi O; Memo M; Spano P Eur J Pharmacol; 1995 Mar; 275(3):311-4. PubMed ID: 7768301 [TBL] [Abstract][Full Text] [Related]
34. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Marion DW; Puccio A; Wisniewski SR; Kochanek P; Dixon CE; Bullian L; Carlier P Crit Care Med; 2002 Dec; 30(12):2619-25. PubMed ID: 12483048 [TBL] [Abstract][Full Text] [Related]
35. Effects of aniracetam, a nootropic drug, in senile dementia--a preliminary report. Mizuki Y; Yamada M; Kato I; Takada Y; Tsujimaru S; Inanaga K; Tanaka M Kurume Med J; 1984; 31(2):135-43. PubMed ID: 6521417 [No Abstract] [Full Text] [Related]
36. The AMPA receptor allosteric potentiator PEPA ameliorates post-ischemic memory impairment. Sekiguchi M; Yamada K; Jin J; Hachitanda M; Murata Y; Namura S; Kamichi S; Kimura I; Wada K Neuroreport; 2001 Sep; 12(13):2947-50. PubMed ID: 11588608 [TBL] [Abstract][Full Text] [Related]
38. Piracetam and aniracetam antagonism of centrally active drug-induced antinociception. Galeotti N; Ghelardini C; Bartolini A Pharmacol Biochem Behav; 1996 Apr; 53(4):943-50. PubMed ID: 8801601 [TBL] [Abstract][Full Text] [Related]
39. Quantitative EEG during progressive hypocarbia and hypoxia. Hyperventilation-induced EEG changes reconsidered. Van der Worp HB; Kraaier V; Wieneke GH; Van Huffelen AC Electroencephalogr Clin Neurophysiol; 1991 Nov; 79(5):335-41. PubMed ID: 1718705 [TBL] [Abstract][Full Text] [Related]
40. [Interrelations of hypocapnia, hypoxia, cerebral blood flow and electrical activity of the brain under voluntary hyperventilation in humans]. Burykh EA Ross Fiziol Zh Im I M Sechenova; 2007 Sep; 93(9):982-1000. PubMed ID: 18030797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]